Trials / Unknown
UnknownNCT04730050
A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy Subjects
A Phase I, First-In-Human, Randomized, Double Blind, Placebo Controlled, Single Ascending-Dose and Multi Ascending Dose Study of TT-01025-CL in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety, tolerability and pharmacokinetic characteristics of TT-01025 in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TT-01025-CL | Oral tablet |
Timeline
- Start date
- 2021-02-17
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-01-29
- Last updated
- 2021-11-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04730050. Inclusion in this directory is not an endorsement.